(Q68092948)
Statements
The in vitro function of lymphocytes from 25 cancer patients receiving four to seven consecutive days of recombinant IL-2 (English)
Rosenthal NS
Hank JA
Kohler PC
Minkoff DZ
Moore KH
Bechhofer R
Hong R
Storer B